Biosign Technologies Inc

Biosign Technologies Inc currently markets our FDA-cleared Healthanywhere™ remote patient monitoring solutions to customers in both Canada and the United States, and we are aggressively pursuing new opportunities in both markets. A recent Frost & Sullivan survey estimates the American market for Home BP monitors at $939 Million, Automated BP meters at $300 Million and Health Stations at $36 Million, while iData estimates the US market for Telemedicine Services will reach$3.6 Billion by 2015. Biosign’s innovative Pulsewave™ Monitor is FDA-cleared and Health Canada licensed and is also marketed to customers in both Canada and the United States.